BCL2 and Hepatic fibrosis: Notably, its administration mitigated the progression of radiation-induced liver fibrosis, likely through the modulation of key apoptotic signaling pathways, such as the Bax/Bcl-2 axis, and the reduction in oxidative stress markers, including superoxide dismutase (SOD) and malondialdehyde (MDA).